| Status | Study |
| Recruiting |
Study Name: Rate of Progression in USH2A Related Retinal Degeneration Condition: Usher Syndrome, Type 2A Retinitis Pigmentosa 39 Date: 2017-05-04 |
| Recruiting |
Study Name: Parents as the Primary Sexuality Educators for Their Young Adults With Down Syndrome Condition: Down Syndrome Intellectual Disability Sexuality Date: 2017-04-27 Interventions: Behavioral: Parent training Participants will attend 3 trainings. There will be a pre-test before traini |
| Completed |
Study Name: Effects of Infant Massage on Acceptance, Commitment and Conscience of Influence of Parents With Down Syndrome Babies Condition: Parent-Child Relations Date: 2017-04-20 Interventions: Other: Infant Massage course Infant massage courses consis |
| Recruiting |
Study Name: Single Dose Pharmacokinetic (PK) Study Condition: Angelman Syndrome Fragile X Syndrome Date: 2017-04-06 Interventions: Drug: OV101 Single-dose 5 mg OV101 Other Name: Gabox |
| Recruiting |
Study Name: Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS) Condition: Confirmed Genetic Diagnosis of Prader-Willi Syndrome Date: 2017-04-03 Interventions: Drug: Tesofensine/Metoprolol S |
| Not yet recruiting |
Study Name: Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory Condition: Prader-Willi Syndrome Date: 2017-03-23 Interventions: Behavioral: Listening Project Protocol The filtered music intervention will consist of listening to comp |
| Recruiting |
Study Name: A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome Condition: Barth Syndrome Date: 2017-03-21 Interventions: Drug: Elamipretide 40 mg daily subcutaneous injection for 12 weeks |
| Recruiting |
Study Name: Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies Condition: Proteus Syndrome PIK3CA-Related Overgrowth Spectrum (PROS) Date: 2017-03-17 Interventions: Drug: ARQ 092 Subjects will receive ARQ 092 orally at the dose level and administration schedule specifi |
| Recruiting |
Study Name: Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances Condition: Sleep Disturbances in Smith-Magenis Syndrome Date: 2017-03-16 Interventions: Other: Data collection of sleep disturbances in individuals with SMS Data related to Smith-Magenis syndr |
| Recruiting |
Study Name: Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years Condition: Prader-Willi Syndrome Date: 2017-03-10 Interventions: Drug: Oxytocin The study drug |